Abstract
Encapsulation of hemoglobin, the primary oxygen carrier, within a vesicle consisting of a semi-permeable membrane and an aqueous inner core may solve several of the problems presented by cell-free hemoglobin solutions. In anticipation of this, liposome-encapsulated hemoglobin products are now being actively developed as a second-generation red cell substitute (Rudolph 1995). The semi-permeable membrane permits free diffusion of gases between hemoglobin and tissues and provides a barrier that prevents large or charged molecules from moving across the membrane. These vesicles provide an efficient oxygen transport system by maintaining hemoglobin at a relatively high concentration within the membrane envelope, while isolating it from damaging components present in blood plasma and, conversely, protecting the endothelial tissue or blood components from cytotoxic effects of free hemoglobin molecules.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akama, K., K. Morizawa, S. Tokuyama, T. Satoh, K. Kobayashi, S. Sekiguchi, and E. Tsuchida. Oxygen transport and in vivo parameters of artificial red cells (ARC). Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 901–907, 1994.
Alayash, A.I., and R.E. Cashon. Hemoglobin and free radicals: implications for the development of a safe blood substitute. Molecular Medicine Today 1: 122–127, 1995.
Allen, T.M. Stealth® liposomes: avoiding reticuloendothelial uptake. In Liposomes in the Therapy of Infectious Diseases and Cancer (G. Lopez-Berestein and I.J. Fidler, Eds.) New York: Alan R. Liss 1989, pp. 405–415.
Azmin M.N., A.T. Florence, R.M. Handjani-Vila J.F. Stuart, G. Vanlerberghe G, and J.S. Whittaker. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J. Pharm. Pharmacol. 37: 237–242, 1985.
Bailie, A.J., A.T. Florence, L.R. Hume, G.T. Muirhead, and A. Rog-erson. The preparation of niosomes~non-ionic surfactant vesicles. Pharm. Pharmacol. 37: 863–868, 1985.
Bangham, A.D., M.M. Standish, and J.C. Watkins. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13: 238–252, 1965.
Beissinger, R.L., M.C. Farmer, and J.L. Gossage. Liposome-encapsulated hemoglobin as a red cell surrogate. Trans. Am. Soc. Artif. Intern. Organs 32: 58–63, 1986.
Berger, R.L., B. Balko, and H.F. Chapman. High resolution mixer for the study of the kinetics of rapid reactions in solution. Rev. Sci. Inst. 39: 493–498, 1968.
Blantz, R.C., A.P. Evan, and F.B. Gabbai. Red cell substitutes in the kidney. In Blood Substitutes: Physiological Basis of Efficacy (R.M. Winslow, K.D. Vandegriff and M. Intaglietta, Eds.) Boston: Birkhauser, 1995, pp. 132–142.
Chang, T.M.S. Hemoglobin corpuscles. Report of a research project of B.Sc. Honours Physiology, McGill University, Medical Library, Mclntyre Building, McGill University, 1957, pp. 1–25.
Chang, T.M.S., F.C. Macintosh, and S.G. Mason. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 44: 115–128, 1966.
Clerc, S.G., and T.E. Thompson. A possible mechanism for vesicle formation by extrusion. Biophys. J. 67: 475–477, 1994.
Cliff, R.O., F. Ligler, B. Goins, P.M. Hoffman, H. Spielberg, and A.S. Rudolph. Liposome encapsulated hemoglobin: long term storage and stability. Biomat. Artif. Cells Immobil. Biotech. 20: 619–626, 1992.
Djordevich, L., and I.F. Miller. Synthetic erythrocytes from lipid-encapsulated hemoglobin. Exp. Hematol. 8: 584–592, 1980.
Domokos, G., B. Jopski, and K.-H. Schmidt. Preparation properties and biological function of liposome encapsulated hemoglobin. Biomat. Artif. Cells Immobil. Biotech. 20: 345–354, 1992.
Farmer, M.C. and B.P. Gaber. Liposome-encapsulated hemoglobin as an artificial oxygen-carrying system. Meth. Enzymol. 149: 184–200, 1987.
Fendler, J. Membrane mimetic chemistry. New York: John Wiley Sons, 1982.
Feola, M., J. Simoni, P.C. Canizaro, R. Tran, G. Raschbaum, and F.J. Behal. Toxicity of polymerized hemoglobin solutions. Surg. Gynecol. Obstet. 166: 211–222, 1988.
Gaber, B.P., P. Yager, J.P. Sheridan, and E.L. Chang. Encapsulation of hemoglobin in phospholipid vesicles. FEBS Lett. 153: 285–288, 1983.
Gershfeld, N.L., CP. Mudd, K. Tajima, and R.L. Berger. Critical temperature for unilamellar vesicle formation in dimyristoylphosphati-dylcholine dispersions from specific heat measurements. Biophys. J. 65: 1174–1179, 1993.
Gregoriadis, G. Drug entrapment in liposomes. FEBS Lett. 36: 292–296, 1973.
Gregoriadis, G. Enzyme entrapment in liposomes. Meth. Enzymol. 44: 218–227, 1976.
Hamilton, P.B., A* Miller, and D.D. Van Slyke. Renal effects of hemoglobin infusions in dogs in hemorrhagic shock. J. Exp. Med. 86: 477, 1947.
Hargreaves, W.R., and D.W. Deamer. Liposomes from ionic, single chain amphiphiles. Biochemistry 17: 3759–3768, 1978.
Hess, J.R., V.W. Macdonald, C.S. Gomez, and V. Coppes. Increased vascular resistance with hemoglobin-based oxygen carriers. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 361–372, 1994.
Hunt, CA., R.R. Burnette, R.D. MacGregor, A.E. Strubbe, D.T. Lau, N. Taylor, and H. Kawada. Synthesis and evaluation of a prototypal artificial red cell. Science 230: 1165–1168, 1985.
Kaca, W., R.L Roth, and J. Levin. Hemoglobin, a newly recognized lipopolysaccharide (LPS) binding protein which enhances LPS biological activity. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 387–398, 1994.
Kugiyama, K., SA. Kerns, J.D. Morrisett, R. Roberts, and P.D. Henry. Impairment of endothelium-dependent arterial relaxation by ly-solecithin in modified low-density lipoproteins. Nature 344: 160–2, 1990.
LaBrake, C.C., and Fung, L.W.-M. Phospholipid vesicles promote human hemoglobin oxidation. J. Biol. Chem. 267: 16703–16711, 1992.
Lasic, D.D., F.J. Martin, A. Gabizon, S.K. Huang, and D. Papahad-jopoulos. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070: 187–192, 1991.
Ligler, F.S., L.P. Stratton, and AS. Rudolph. Liposome encapsulated hemoglobin: stabilization, encapsulation and storage. InThe Red Cell: Seventh Ann Arbor Conference New York: Alan R. Liss, Inc., 1989, pp. 435–455.
Manning, J.M. Design of chemically modified and recombinant hemoglobins as potential red cell substitutes. In Blood Substitutes: Physiological Basis of Efficacy (R.M. Winslow, K.D. Vandegriff and M. Intaglietta, Eds.) Boston: Birkhauser 1995, pp. 76–89.
Matsuda N., K. Nakai, M. Amano, TA. Takahashi, T. Ohta, I. Sakuma, A. Kitabatake, Y. Nakazato, and S. Sekiguchi. The quality control of stroma-free hemoglobin: lysophosphatidylcholine, a component of stromal phospholipids, as candidate vasoconstrictive factor. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 939–944, 1994.
Nakai, K., N. Matsuda, M. Amano, T. Ohta, S. Tokuyama, K. Akama, Y. Kawakami, E. Tsuchida, and S. Sekiguchi. Acellular and cellular hemoglobin solutions as a vasoconstrictive factor. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 559–564, 1994.
Panter, S.S., K.D. Vandegriff, P.O. Yan, and R.F. Regan. Assessment of hemoglobin-dependent neurotoxicity: alpha-alpha crosslinked hemoglobin. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 399–413, 1994.
Papahadjopoulos, D. (Ed.) Ann. N.Y. Acad. Sci. 308, 1978.
Philippot, J.R., S. Mutaftschiev, and J.P. Liatard. A very mild method allowing the encapsulation of very high amounts of macromole-cules into very large (1000 nm) unilamellar liposomes. Biochim. Biophys. Acta 734: 137–143, 1983.
Presti, F.T., and S.I. Chan. Cholesterol phospholipid interactions in membranes. I. Cholestane spin-label studies of phase behavior of cholesterol-phospholipid liposomes. Biochemistry 21: 3821–3830, 1982.
Rudolph A.S., R.O. Cliff, R. Klipper, B. Goins, and W.T. Phillips. Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid. Crit. Care Med. 22: 42–50, 1994.
Rudolph, A.S. Encapsulated hemoglobin: current issues and future goals. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 347–360, 1994.
Rudolph, A.S. Encapsulation of hemoglobin in liposomes. In Blood Substitutes: Physiological Basis of Efficacy (R.M. Winslow, K.D. Vandegriff and M. Intaglietta, Eds.) Boston: Birkhauser 1995, pp. 90–104.
Simoni, J., M. Feola, and P.C. Canizaro. Generation of free oxygen radicals and the toxicity of hemoglobin solutions. Biomat. Artif Cells Artif. Org. 18: 189–202, 1990.
Smith, CD., S.T. Schuschereba, J.R. Hess, L. McKinney, D. Bunch, and P.D. Bowman. Liver and kidney injury after administration of hemoglobin cross-linked with bis(3,5-dibromosalicyl)fumarate. Biomat. Artif Cells Artif. Org. 18: 251–261, 1990.
Surgenor, D.M., and D.F.H. Wallach. Biophysical aspects of platelet reaction mechanisms in clotting. In Henry Ford Hospital International Symposium, Blood Platelets. (S.A. Johnson, Ed.) Boston: Little Brown Co, 1961.
Szebeni, J., CC Winterbourn, and R.W. Carrell. Oxidative interactions between hemoglobin and membrane lipid. A liposome model. Bio-chem. J. 220: 685–692, 1984.
Szebeni, J., E.E. Di Iorio., H. Hauser, and K.H. Winterhalter. Encapsulation of hemoglobin in phospholipid liposomes: characterization and stability. Biochemistry 24: 2827–2832, 1985.
Szebeni, J., N.M. Wassef, H. Spielberg, A.S. Rudolph, and CR. Alving. Complement activation in rats by liposomes and liposomeencapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation. Biochem. Biophys. Res. Comm. 205: 255–263, 1994.
Szoka, F.C., F. Olson, T. Heath, W.J. Vail, E. Mayhew, and D. Pa-pahadjopoulos. Preparation of unilamellar liposomes of intermediate size (0.1–0.2 urn) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim. Biophys. Acta 601: 559–571, 1980.
Takahashi, A. Characterization of neo red cells (NRC), their function and safety in vivo tests. Artif. Cells, Blood Substitutes, Immobil. Biotech. 23: 347–354, 1995.
Tanford, C. The Hydrophobic Effect. New York: John Wiley and Sons, 1980.
Tsai, A.G., H. Kerger, and M. Intaglietta. Microcirculatory consequences of blood substitution with aoe-hemoglobin. In Blood Substitutes: Physiological Basis of Efficacy (R.M. Winslow, K.D. Vandegriff and M. Intaglietta, Eds.) Boston: Birkhauser 1995, pp. 155–174.
Tsuchida, E. Synthesis and characterization of artificial red cell (ARC). Biomat. Artif. Cells, Immobil. Biotech. 20: 337–344, 1992.
Tsuchida, E. Stabilized hemoglobin vesicles. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 467–477, 1994.
Usuba, A. and R. Motoki. Safety and efficacy of encapsulated hemoglobin in hemorrhagic shock. In Artificial Red Cells (E. Tsuchida, Ed.) Chichester: John Wiley Sons Ltd, 1995, pp. 65–92.
Usuba, A, R. Motoki, K. Suzuki, K. Sakaguchi, and A. Takahashi. Study of effect of the newly developed “neo red cells” (NRC) on hemodynamics and blood gas transport in canine hemorrhagic shock. Biomat. Artif. Cells Artif. Org. 20: 531–535, 1992.
Vandegriff, K.D., D.F.H. Wallach, and R.M. Winslow. Encapsulation of hemoglobin in non-phospholipid vesicles. Artif. Cells, Blood Substitutes, Immobil. Biotech. 22: 849–854, 1994.
Vivier, A., J.-C. Vuillemard, H.-W. Ackerman, and D. Poncelet. Large-scale blood substitute production using a microfluidizer. Biomat. Artif. Cells Immobil. Biotech. 20: 377–397, 1992.
Wallach, D.F.H., PA Maurice, BA. Steele, and D.M. Surgenor. Studies on the relationship between the colloidal state and the clot-promoting activity of pure phosphatidylethanolamines. J. Biol. Chem. 234: 2829–2834, 1959.
Wallach, D.F.H., and J.R. Philippot. In Liposome Technology 2 Edition (G. Gregoriadis, Ed.) Boca Raton: CRC Press, 1993, pp. 141–156.
Wallach, D.F.H., and C. Yiournas. Method and apparatus for producing lipid vesicles. U.S. Patent Number 5,013,497, 1990.
White, C.T., A.J. Murray, D.J. Smith, J.R. Greene, and R.B. Bolin. Synergistic toxicity of endotoxin and hemoglobin. J. Lab. Clin. Med. 108: 132–137, 1986.
Winslow, R.M. Hemoglobin-based Red Cell Substitutes. Baltimore: Johns Hopkins University Press, 1992.
Winterhalter, M., and D.D. Lasic. Liposome stability and formation: experimental parameters and theories on the size distribution. Chem. Phys. Lipids 64: 35–43, 1993.
Woodle, M.C., and D.D. Lasic. Sterically stabilized liposomes. Bio-chim. Biophys. Acta 1113: 171–199, 1992.
Yoshida, Y., K. Kashiba, and E. Niki. Free radical-mediated oxidation of lipids induced by hemoglobin in aqueous dispersions. Biochim. Biophys. Acta 1201: 165–172, 1994.
Zheng, S., Y. Zheng, R. Beissinger, and R. Fresco. Liposome-encapsulated hemoglobin processing methods. Biomat. Artif. Cells Immobil. Biotech. 20: 355–364, 1992.
Zheng, S., Y. Zheng, and R. Beissinger. Efficacy, physical properties and pharmacokinetics of sterically-stabilized liposome encapsulated hemoglobin. Artif Cells, Blood Substitutes, Immobil. Biotech. 22: 487–501, 1994.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Birkhäuser Boston
About this chapter
Cite this chapter
Rohlfs, R.J., Vandegriff, K.D. (1996). Non-phospholipid Liposomes: A Novel Method for the Preparation of Hemoglobin Containing Lipid Vesicles. In: Winslow, R.M., Vandegriff, K.D., Intaglietta, M. (eds) Blood Substitutes. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4114-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4114-0_11
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4612-8659-2
Online ISBN: 978-1-4612-4114-0
eBook Packages: Springer Book Archive